BCHMF (Bachem Holding AG) Other Stockholders Equity: $-77.1 Mil (As of Dec. 2025)


BCHMF Bachem Holding AG BCHMF
91 GF Score
Price $87.34
GF Value $116.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bachem Holding AG Other Stockholders Equity?

Bachem Holding AG BCHMF 91 Other Stockholders Equity is $-77.1 Mil as of Dec. 2025. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $116.99 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Bachem Holding AG's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-77.1 Mil.

Bachem Holding AG's quarterly Other Stockholders Equity declined from Dec. 2024 ($-48.4 Mil) to Jun. 2025 ($-74.5 Mil) and declined from Jun. 2025 ($-74.5 Mil) to Dec. 2025 ($-77.1 Mil).

Bachem Holding AG's annual Other Stockholders Equity increased from Dec. 2023 ($-61.2 Mil) to Dec. 2024 ($-48.4 Mil) but then declined from Dec. 2024 ($-48.4 Mil) to Dec. 2025 ($-77.1 Mil).

Bachem Holding AG Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bachem Holding AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bachem Holding AG Other Stockholders Equity Chart

Bachem Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.76 -44.40 -61.23 -48.37 -77.12

Bachem Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.23 -49.61 -48.37 -74.51 -77.12
BCHMF
91GF Score
Bachem Holding AG BCHMF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bachem Holding AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-77.1 Mil mean?
Bachem Holding AG (BCHMF) has a Other Stockholders Equity of $-77.1 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bachem Holding AG and its competitors.
Is Bachem Holding AG's Other Stockholders Equity too high?
Bachem Holding AG's current Other Stockholders Equity is $-77.1 Mil. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Other Stockholders Equity compare to VRTX and REGN?
Bachem Holding AG's Other Stockholders Equity of $-77.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bachem Holding AG and its competitors. Bachem Holding AG's current Other Stockholders Equity is $-77.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.99, compared to a current price of $87.34 — trading 25.3% below its estimated fair value. The current Other Stockholders Equity is $-77.1 Mil. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Other Stockholders Equity is $-77.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bachem Holding AG (BCHMF) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of $87.34 is trading 25.3% below its estimated GF Value™ of $116.99. GuruFocus considers Bachem Holding AG to be Modestly Undervalued.

Key valuation signals for BCHMF:

  • Other Stockholders Equity: $-77.1 Mil
  • GF Value™: $116.99 vs. price of $87.34 (25.3% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score

Get the complete analysis for BCHMF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$87.34
Price
$116.99
GF Value